2.01

9.24% 0.17

Black Diamond Therapeutics Inc (BDTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.84

Aprire:

$1.83

Volume 24 ore:

1.57M

Relative Volume:

0.98

Capitalizzazione di mercato:

$115.18M

Reddito:

$70.00M

Utile/perdita netta:

$-43.21M

Rapporto P/E:

-2.6521

EPS:

-0.7579

Flusso di cassa netto:

$-34.03M

1 W Prestazione:

+18.24%

1M Prestazione:

-7.80%

6M Prestazione:

-19.28%

1 anno Prestazione:

-22.69%

Intervallo 1D:

$1.83

$2.035

Intervallo di 1 settimana:

$1.68

$2.035

Portata 52W:

$1.60

$4.94

Black Diamond Therapeutics Inc Stock (BDTX) Company Profile

Nome

Black Diamond Therapeutics Inc

Settore

Healthcare (1098)

Industria

Biotechnology (615)

Telefono

617-417-5868

Indirizzo

245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

BDTX's Discussions on Twitter

Compare BDTX vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BDTX Black Diamond Therapeutics Inc	2.01	106.01M	70.00M	-43.21M	-34.03M	-0.7579
VRTX Vertex Pharmaceuticals Inc	528.04	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	654.27	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	939.68	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	312.78	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.24	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-03	Downgrade	Guggenheim	Buy → Neutral
2025-11-18	Ripresa	Piper Sandler	Overweight
2025-10-16	Ripresa	Stifel	Buy
2025-09-04	Iniziato	Guggenheim	Buy
2025-07-01	Ripresa	Raymond James	Outperform
2024-07-31	Iniziato	Raymond James	Outperform
2023-07-14	Iniziato	Piper Sandler	Overweight
2023-06-30	Aggiornamento	Stifel	Hold → Buy
2023-06-28	Aggiornamento	H.C. Wainwright	Neutral → Buy
2023-06-27	Aggiornamento	Wedbush	Neutral → Outperform
2022-03-29	Downgrade	Wedbush	Outperform → Neutral
2022-03-22	Downgrade	H.C. Wainwright	Buy → Neutral
2021-09-30	Iniziato	Stifel	Hold
2021-01-07	Iniziato	Wedbush	Outperform
2020-11-24	Iniziato	Berenberg	Buy
2020-05-04	Iniziato	H.C. Wainwright	Buy
2020-02-24	Iniziato	Canaccord Genuity	Buy
2020-02-24	Iniziato	Cowen	Outperform
2020-02-24	Iniziato	JP Morgan	Overweight
2020-02-24	Iniziato	Jefferies	Buy

Mostra tutto

Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie

Jun 30, 2026

Black Diamond Therapeutics touts Silevertinib lung cancer data, eyes FDA path - MSN

Jun 30, 2026

Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash - Moomoo

Jun 30, 2026

Jun 29, 2026

Black Diamond Therapeutics 2026 Annual Stockholder Meeting Results and Voting Outcomes - Minichart

Jun 29, 2026

Form 4 Black Diamond Therapeutics Inc For: 29 June By Investing.com - Investing.com Nigeria

Jun 29, 2026

[Form 4] Black Diamond Therapeutics, Inc. Insider Trading Activity - Stock Titan

Jun 29, 2026

Black Diamond (BDTX) director awarded 40,000 stock options at $1.71 - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics (BDTX) director awarded 40,000 stock options at $1.71 - Stock Titan

Jun 29, 2026

Director Garry Menzel granted 40,000 BDTX stock options at $1.71 strike - Stock Titan

Jun 29, 2026

Black Diamond (NASDAQ: BDTX) director receives 40,000 stock options at $1.71 - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics (BDTX) awards 40,000-share option grant - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics (BDTX) 2026 meeting backs directors, auditor and annual say-on-pay - Stock Titan

Jun 29, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS: BDTX) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Enterprise value to EBITDA forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView

Jun 29, 2026

Jun 28, 2026

Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 3000 Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Black Diamond Therapeutics (BDTX) AGM 2026 Summary - Quartr

Jun 26, 2026

Price to sales forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView

Jun 26, 2026

Price to book forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 26, 2026

Black Diamond Therapeutics, Inc. Actuals & Estimates (NASDAQ:BDTX) - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBIT forward of Black Diamond Therapeutics, Inc. – NASDAQ:BDTX - TradingView

Jun 25, 2026

Price to earnings forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 25, 2026

Price to sales forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 25, 2026

Enterprise value to revenue forward of Black Diamond Therapeutics, Inc. – BOATS:BDTX - TradingView

Jun 25, 2026

BDTX shares gain 11% in a week: Here's what you should know - MSN

Jun 25, 2026

BDTX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 23, 2026